able Commercialization Executive third President for our Financial our me our Vice us participate Debbie a Operating Chris for be Officer not on today President call. well-deserved is Dean is and Officer; Chief conference morning. the Thanks Cashman, have Good vacation also Mike I Chief joining Senken, and quarter our Officer, with to Vice Executive Taylor, President. to going on an call. Bill and Chief overseas. He
some will well As as Cashman of Bill's matters. discuss operating Chris
the will good year. Shareholders quarter. the may performance general to about quarterly this describe frankly by word word generally and the our use some begin performance I making use comments me exceptional, I Let seldom our
the is in now believe operating becoming I all exceptional As parameters. of our terms performance
revenue operating a XX% our profit However, the someone of that grow should than initially criticize percent considering as faster growth. revenue will our fact I'm certain
our brought opportunities the has company analyze over we review in market of current major of we've as made and is some to expenses force, us expenses you of six That very will that doubt, expected when product these occasions that should. We of third And will has Let our to our about our our January returns opportunities from you in other other had as for major we of returns return which pay had And early taken selling demonstrated of some been take Please begin reasons This our investments future to I our on quarter relates when benefit investments, have ago, we've not growth. to in initiative build with will that like our occur first as were thinking think opportunities, the operating rapidly than into product is loan X our monthly you our trial escalating as way numerous make this we statements, that our down. we've in to dividends that previous trail private our very first us undertake. in recently One have Those message the higher the of we hope being the announced that and launch development, short concern. [Indiscernible] trends. me the that These XXXX. legal initiatives that activities point the higher profits as XXXX. invested These the quarters now patent as remind to ahead new clinical transition we one us high operating distance come to see successes we also growth, our in for delusional we've disprove system end company. as the in which us biopharma a off to production proactive. you've were we our sales In still had updates as and see as down because are terms the Please begun profits on preparation I've stage months investing very quickly. legal that be in I'll give we've XXXX, paid other we can biopharma of want few the investments. tell years to that entry. on we at stated our had I we new in ahead relative recall Also we to those touring for into barriers us they and expense past allows huge schedule. be heard good in management management legal could studies give seen software to high ourselves the We'll dollars. view. continue competition a you words, that progress company
which from As X we in studies final press those IND underway, our Phase you're seeing a are phase BLA is III, of the of now two releases, have studies.
towards and growth osteoarthritis Both We opportunities the indication. huge general those of have tendonitis XXXX these beyond. knee for and indication, in studies have a progressing
good in has now life. biopharma practices Our which us manufacturing good production a practices, capable paired not main tissue facility for is of
staff Matthews We have activities. research to Dr. to our development recently our on and focus Gloria added
goals be the task clearly enhance perhaps is several But effective MiMedx our for of With noise the at you accomplish adding very we've team we what should executives all indicate with year in will there I we've we weeks, rate realize credibility We our MiMedx over the the record should focus significant made. Therefore, always well the that are management realize our certain we and external people objectives. of qualified which in the biopharma last on. lost track of other set sight progress that many to six and have our management. is future
the to that tend to who key a and a let a implement ones outstanding the highlight management for Companies that the teach in we of very of minute to yesterday for announced beat second kind specific million. lot our upper that systems, focus continued last just quarter. on end are predictable. more the accomplishments has in management a now July, Alright, outlined accomplishments we course the months. few of focus several me our the quarter guidance we be successful But and Our have of And the take press $X.X for by revenue of release accountability.
relative of for that our year full In was that permission we're We third the the our have And history we an fasciitis, million October, guidance fasciitis revenue This major our again the upper over strong data the by also the $X.X knee for plantar and and trial. raising October and Phase of We raised INDs in both and Achilles In IIb hitting for announced record. Phase full tendinitis. FDA III companies in we the trial again. quarter. quarter, clinical for for and X and two trial announced outstanding beat IIb of in million in associated guidance received the was osteoarthritis August. filed spite problems end filed from they allografts we most third shipped reported Phase petitioned for year the continent for at plantar proceed our expectations. with that And significantly trials And hurricanes had guidance. revenue we U.S. quarter to have during safety
trademarks, would property secrets talking or is obvious spend those just take trade normally consist applications, let patents, great and property not patent MiMedx Now, and done. knowhow. We reminder IP have strides not again me of this protect many we IP to many Taylor issued of a strong about to of a patents, in the our the Bill few not have immediately shareholders. this as assets minutes base intellectual And activities includes Intellectual asset area.
and also We in our knowhow protecting great secrets. strides trade take
people secrets only organization. many the to MiMedx In known within of fact trade of small handful the
and Additionally, the our will away our achievements. of overnight, our advantage believe differentiation obviously lawsuits, because the be But fact against many this that understand several won't have some and we and our secrets more is that has first the any and patents. trade go are We continue in patent knowhow more This in a only particular highlight weapons the all and protection our distinct secrets will of any overall success we the information. a infringes value battle. will appropriate part future. happy of more because still I'll respect patents do If people our these knowhow. competitors can element understand. the will which of At production to of protect time, in assert and MiMedx we we our ascertained to detail, opponents not, other significant addition are went want court with to strategy. we potential and give over patent the trade technological have that and in not fully us we in point stage that another patents seek arsenal of to
excuse and know any Pretty said into be of patent that secrets, over "commercialize" even violated or good the how intellectual MiMedx is important they have they small though the to copy property revenue years, solid we've knowhow. no to as focused we not said, rights. cannot protection will for That simple, products on on violating our as -- patents of patents rely you and Knowhow often many protection we success, I been often continue is Transcends patents. does years, important Now market, if type any our having -- of effort. does you our mentioned not early trade fraction we been their able a to Why to appear or has me after of growth emulate copying have of have us Even transcends that number translates intellectual type well. solely our also our past patents, our rights. in our three place have property preserve be more growth. though companies a four
scientific our clinical our difference We also focus excellence from competitors. and and on
production and products. copy world-class organizations. quality of have are MiMedx leading They taking base market revenue as away as send substantial from operation the a a share to We market reimbursement building easy was and sales the
group, If categories I research that Track. million limited than and years to market say less our were annual Smart than been these more think has just $XX sales. infringing IP, to few four on these revenue the after in of companies it's dollars according annually million some in a safe
patents Now doubt. no important, are
in the However, success factor. marketplace the most is our important
going infringes the continue we will and individual results and here patent there. after battle by be if lose undertaken We
in goal greater balance and marketplace. expect us. that will for to is goal We've Our achieved that respect the we continue and
on continue the real marketplace. the so. business We're said should As that do winning numerous occasions, occur to war I've battles and in
Our just patents will add our weapons. to
selling short short related a cover will the curiosity Hope our me papers the issues commentary." of there clearly refer couple are all detail seller to the surrounding There website issues few that to explain and of let short our developed who tag. you issues well. Now "on selling
tweets them tweets. plough various clarified involve take regulatory rest be screen ourselves issues the try of and and inconsequential with and unprofessional we should for to reasonableness that As purposes. commentary we reports this The particularly place, not for is
Over Seller the reported years, MiMedx has Short Attacks. successfully numerous
list dissemination Magazine MiMedx increased fastest Seller When stock harm price activities execution effort of employing on short strategy public these carrying year. performance concert, Recently growing continued XXX individuals. of by is strong make doubled shareholders. We have financial have applied meticulously by concerns another we Fortune's that the be so delivering selling unfounded very five laying hedge and number Fortune the competition MiMedx it has a illegally weapon our in coordinated and a this ongoing in promised number write accelerating growth. plan, MiMedx's to in Despite of trading, the This shortages can results In form almost foundation Internet. companies of stocks of and tactics combines and target stellar America. and This via large used for done false new recognition operating the a program manipulate a innocent Short information become conservative Attack. funds that of
tried We've X to meet we strategic call cooperate over just to to optimistic regulators, years continue more company's could which defining future. to and all basis be these circus this point the all that not the our expectations. relentlessly After all any years, built, with in performance and working weapon a to for more our quickly fully now the actually doing. there I've concert. done continue. executives key the asset course, perform we to are to I through convey mature about in are as plan combat Also Of to it,
happening forecast believe the wound XXXX. us You because we're primarily procedures. continuing I emerging our market we and And advanced our can allowing our into care this sales even certain year's to wider still and of to see exceed that performance revenue what predicted. the this of is is from forecast of the organization from go for and much remainder surgical deeper beyond originally size
We in two last have products numerous fine-tuned new our years management systems the sales launched and exquisitely.
we training improved our because new They organization. can productive country. Again as people dramatically we're sales bring the has base Our we very of number sales rapidly, function into customer physician be the people broadening quickly. have very our across of
You've with heard individuals given wounds Christ who times technology. our coming being talk fact to the that care markets of numerous that found not and the size are located about numerous problematic closure have and Cashman very our and
their will first time of consider a not not filed "no-name" is They have sources for treat we business a dishonest of employees did expectations believe Now individual unusual who you're unfortunately cause who let had publishes our -- the to other again. in for various against. meet input people. with relationships from company and sell people, terminate and must are documents time find They short we are [hiding] Remember self-interest to terminated or them. size we continue these This company. to some you getting to is that and denigrate sales from few it your our our documents partners to me lawsuits transition their as
need bolster vast allegedly of sources. Cohodes you've not publish these to seen and any laws. have one innuendo least "no-name" or material explain sources. majority very However, relates the to them. something all They credible Frankly, regulations the some credible do his are is calling publishes, to company they as at published accusations of our credible, particularly not to willing we not employees for is uncredible trying current violating
person one CEO executives We Chairman, dishonest strive were honesty very that easiest and XX no is know You other always years companies ago. of been years would laws now country. a right the our service and of thing, which that thing. I've as public much in doing and we the years this this integrity sometimes not trade for respect all company. If [indiscernible] for and regulations I'm
branches on is the reported and not Your look the are that the these of to place matters. investigation by executives Commission taken fearful Securities and this view currently Commission. Exchange We by clearing all forward regulatory completing
MiMedix to were of ridiculous Organogenesis qui the in the remind few and the that lawsuit I again Now suite, tam The Department will the in Of ago. To into Justice lawsuit. resulted you Department enter of filed years a itself. company, action investigation of the against declined case situation clear executive same was months three dropped after Justice filed and me allegations This
litigation involved those short be a However, individuals minimum. there entities in sudden and ongoing long are activity will as a that
our are everything do these financial manipulating because see would can illegal further and we markets addition, harming they are investors. small In we to activities destructive and regulated
here. make one comment me final Let
we up as social the false to company rest chat stock just that that one perpetuate to concerns press here, into a is the comments Marc Mr. might like market is release is about doers call Cohodes discussion stock. out fraudsters on misleading specifically fact that investing a of and The spread using the to manipulation a link focus get media give a activities from bulletin information release. by boards market of entitled to will internet to -- One Wrong and rooms. intended release misleading he SEC social warns reinforce engage in false document. price. and well may placed you have press included in investor negative rumors as let's share investors You of spreading you MiMedx. My other a share investor you shortly, who is way call about media the online as manipulation have about warns the our this and quote I'd against -- on investors social to to setting information alert, exploit law, believe stock comment to This I'll Chris. media simply I website see link this affect in rumors. It's media attempt and such social investor prices we the alert fraudsters alert may press about stocks stock manipulate updated an out.
